25264305Shaw AT, Ou SH, Bang YJ, Camidge DR, Solomon BJ, Salgia R, Riely GJ, Varella-Garcia M, Shapiro GI, Costa DB, Doebele RC, Le LP, Zheng Z, Tan W, Stephenson P, Shreeve SM, Tye LM, Christensen JG, Wilner KD, Clark JW, Iafrate AJThe New England journal of medicineCarcinoma, Non-Small-Cell Lung; Lung Neoplasms; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Pyrazoles; PyridinesAdministration, Oral; Adult; Aged; Crizotinib; Disease-Free Survival; Female; Gene Rearrangement; Humans; In Situ Hybridization, Fluorescence; Kaplan-Meier Estimate; Male; Middle Aged; Proto-Oncogene Mas; Treatment Outcome; Vision DisordersCrizotinib in ROS1-rearranged non-small-cell lung cancer. N Engl J Med. 2014 Nov 20; 371(21):1963-71.N Engl J Med2014-09-27T00:00:002014Crizotinib in ROS1-rearranged non-small-cell lung cancer.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000368Living Beings1341183530.294764AgedD000284Procedures2556830.864689Administration, OralD000328Living Beings1578255770.254432AdultD002289Disorders15810730.519149Carcinoma, Non-Small-Cell LungD008875Concepts & IdeasLiving Beings1473249570.258811Middle AgedD008175Disorders32822600.404525Lung NeoplasmsD005260Physiology1992444050.191167FemaleD011505Chemicals & Drugs1183020.866551Protein-Tyrosine KinasesD011518Chemicals & Drugs2306450.750392Proto-Oncogene ProteinsD011725Chemicals & Drugs1533090.839039PyridinesD014786Disorders47750.942985Vision DisordersD006801Living Beings2262862810.130052HumansD008297Physiology1931408600.201617MaleD015321Physiology861700.916065Gene RearrangementD016896Concepts & Ideas101179490.402389Treatment OutcomeD017404Procedures1463480.913343In Situ Hybridization, FluorescenceD011720Chemicals & Drugs841530.896041PyrazolesD053208Concepts & Ideas3258590.818599Kaplan-Meier EstimateAuthorship 6455060.1294050.1294051authors10.2520has subject areaD018572Concepts & Ideas25812030.792696Disease-Free SurvivalD047428Chemicals & Drugs2065890.714193Protein Kinase InhibitorsMedicineUniversity of ChicagoRaviSalgiaRavi Salgia41.78927490000000-87.601250000000001937Salgia, RaviEmeritus/Emerita, Professortrue1Emeritus/Emerita, ProfessorEmeritus/Emerita, Professor